美股異動 | 尚乘數科盤前漲13% 上市半月股價上漲200多倍
格隆匯8月3日丨尚乘數科(HKD.US)盤前漲13.22%,報1901美元,其7.8美元/股發行價的244倍,總市值3517億美元。尚乘數科昨日收漲126.28%報1679美元,市值急升至3107億美元,市值排名全球第26,成交4.1億美元;公司市值盤中飈升至4728億美元,成為全球市值第9大股份,不只超越騰訊,還超越了英偉達、Meta等巨頭。尚乘數科為香港金融股,一年收入約2億港元,生意規模遠不及騰訊, 尚乘數科7月15日上市,上市價7.8美元。其招股文件顯示,未計超額認購綠鞋機制,尚乘國際持有公司88.7%股權及99.4%投票權。尚乘集團由李嘉誠的長江實業集團、和記黃埔於2003年創立,主要業務包括資產管理、投行、保險經紀等。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.